Nektar Therapeutics reported $1.28B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Amgen AMGN:US $ 59196M 1969M
Astrazeneca AZN:US $ 100273M 5090M
Biocryst Pharmaceuticals BCRX:US $ 527.72M 60.43M
Cara Therapeutics CARA:US $ 223.87M 23.19M
Eisai 4523:JP Y 1239315M 71959M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
Exelixis EXEL:US $ 2654.12M 37.88M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Merk MRK:US $ 106668M 974M
Novartis NOVN:VX SF 125218M 6577M
Takeda 4502:JP Y 13178018M 479499M